As cancer rates continue to surge globally, the impact on women is becoming increasingly severe. And, nowhere is this more evident than in Asia Pacific, which accounts for a staggering 45% of all global breast cancer cases and 58% of cervical cancer deaths worldwide.
Yet, we know that tools exist to eliminate cervical cancer as a public health problem and to reduce the incidence of breast cancer. So why is it that in the Asia-Pacific region in particular, incidence and mortality are not decreasing?
Ahead of International Women’s Day 2024, Amy Ho, Head of Disease Areas for Roche Diagnostics APAC, member of Roche’s International Women’s Network and of the Asia-Pacific Women's Cancer Coalition weighs in.

Market View: Netflix shares fall on downbeat forecast, departure of co-founder; Apple’s iPhone shipments in China surge 20% in Q1 per data; Asian stocks down but oil prices below US$100 on peace deal hopes; Singapore’s key exports up 15.3% in March, exceeding forecasts; OpenAI reportedly set to spend more than US$20 billion on Cerebras chips; Yangzijiang Maritime to watch
13:00

Wealth Tracker: Is cash king again amid geopolitical shock?
15:58

The Big Story: Caning, suspensions... Singapore schools get tougher on bullying, but will it make a difference?
12:24